Erste Group upgraded Eli Lilly (LLY) to Buy after strong first-half results, projecting annual revenue between $60-$62 billion and earnings per share between $21.80-$23.00. The company has raised its dividend for 11 consecutive years, with a quarterly dividend of $1.50 per share and a yield of 0.74%.

Eli Lilly (LLY), an American multinational pharmaceutical company, saw its stock surge over 4% since the beginning of 2025. Erste Group upgraded LLY from Hold to Buy on October 13, citing the company’s impressive performance in the first half of the year.

The recent tariff announcements are expected to have a limited impact on Eli Lilly (LLY), with the effects already factored into the company’s updated guidance. Erste Group anticipates that LLY will continue to gain market share within the pharmaceutical industry.

While Eli Lilly (LLY) remains a favorite among dividend investors, certain AI stocks may offer greater upside potential with less downside risk. Investors seeking an undervalued AI stock that could benefit from current trends should explore available reports for more information.

Read more at Yahoo Finance: Erste Group Upgrades Eli Lilly (LLY) to Buy Following Strong First-Half Results